Cited 0 times in Scipus Cited Count

KOBIO, the first web-based Korean biologics registry operated with a unified platform among distinct disease entities

DC Field Value Language
dc.contributor.authorKim, J-
dc.contributor.authorKoh, JH-
dc.contributor.authorChoi, SJ-
dc.contributor.authorJeon, CH-
dc.contributor.authorKwok, SK-
dc.contributor.authorKim, SK-
dc.contributor.authorChoi, CB-
dc.contributor.authorLee, J-
dc.contributor.authorLee, C-
dc.contributor.authorNam, EJ-
dc.contributor.authorPark, YB-
dc.contributor.authorLee, SS-
dc.contributor.authorKim, TH-
dc.contributor.authorPark, SH-
dc.contributor.authorChoe, JY-
dc.contributor.authorKoh, EM-
dc.contributor.authorYoo, DH-
dc.contributor.authorSong, YW-
dc.contributor.authorKim, HA-
dc.contributor.authorShin, K-
dc.date.accessioned2023-01-26T06:10:35Z-
dc.date.available2023-01-26T06:10:35Z-
dc.date.issued2021-
dc.identifier.issn2093-940X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24151-
dc.description.abstractThe KOrean College of Rheumatology BIOlogics and targeted therapy (KOBIO) registry is a nationwide observational cohort that captures detailed data on exposure of patients to biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs). This registry was launched in December 2012 with an aim to prospectively investigate clinical manifestations and outcomes of patients with rheumatoid arthritis (RA), ankylosing spondylitis, and psoriatic arthritis who initiated a biologic or targeted synthetic DMARD or switched to another. Demographic data, disease activity, current treatment, adverse events, terms based on Medical Dictionary for Regulatory Activities, and so on are registered for patients who are then followed up annually in a web-based unified platform. The KOBIO registry also recruits and collects data of patients with RA on conventional DMARDs for comparison. As of today, more than 5,500 patients were enrolled from 47 academic and community Rheumatology centers across Korea. The KOBIO registry has evolved to become a powerful database for clinical research to improve clinical outcomes and quality of treatment.-
dc.language.isoen-
dc.titleKOBIO, the first web-based Korean biologics registry operated with a unified platform among distinct disease entities-
dc.typeArticle-
dc.identifier.urlhttps://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2021.28.4.176-
dc.subject.keywordAnkylosing spondylitis-
dc.subject.keywordBiological products-
dc.subject.keywordPsoriatic arthritis-
dc.subject.keywordRegistries-
dc.subject.keywordRheumatoid arthritis-
dc.contributor.affiliatedAuthorKim, HA-
dc.type.localJournal Papers-
dc.identifier.doi10.4078/jrd.2021.28.4.176-
dc.citation.titleJournal of rheumatic diseases-
dc.citation.volume28-
dc.citation.number4-
dc.citation.date2021-
dc.citation.startPage176-
dc.citation.endPage182-
dc.identifier.bibliographicCitationJournal of rheumatic diseases, 28(4). : 176-182, 2021-
dc.identifier.eissn2233-4718-
dc.relation.journalidJ02093940X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Rheumatology
Files in This Item:
10.4078_jrd.2021.28.4.176.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse